Farydak,
LBH 589,
LBH589,
NVP LBH589,
NVP-LBH589,
panobinostat,
Panobinostat,
404950-80-7,
LBH589,
LBH-589,
Farydak,
Faridak,
LBH 589,
Panobinostat (LBH589),
(E)-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide,
NVP-LBH589,
UNII-9647FM7Y3Z,
LBH-589B,
(E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE,
CHEBI:85990,
9647FM7Y3Z,
Farydak (TN),
(E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide,
N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide,
(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enehydroxamic acid,
(E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)acrylamide,
2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-,
Panobinostat [USAN:INN],
NVP-LBH-589,
(2E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide,
2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)-, (2E)-,
AK-77283,
N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide,
PubChem19147,
Panobinostat(LBH589),
AC1OCFY8,
LBH589 - Panobinostat,
Panobinostat (USAN/INN),
MLS006011216,
NVP-LBH 589,
SCHEMBL164801,
SCHEMBL183197,
CHEMBL483254,
GTPL7489,
BDBM29589,
CHEBI:93774,
DTXSID40193506,
EX-A169,
FPOHNWQLNRZRFC-ZHACJKMWSA-N,
BCPP000187,
BDBM198124,
LBH-589/Panobinostat /LBH589,
AOB87727,
BCP01816,
LBH58,9NVP-LBH589,Panobinostat,
ABP000143,
MFCD09833242,
s1030,
ZINC22010649,
AKOS005146046,
ACN-025765,
BCP9000844,
CCG-208762,
CS-0267,
DB06603,
EX-8456,
RL03555,
SB16464,
NCGC00263117-07,
4CA-0964,
AC-28652,
AJ-80437,
AM808102,
AS-17046,
BC203264,
BR-77283,
HY-10224,
QC-10419,
SC-85907,
SMR004702978,
AB0007883,
AX8223959,
DB-025426,
RT-014934,
ST2402529,
A8178,
FT-0083488,
SW219369-1,
W6096,
EC-000.2287,
A25218,
D10319,
W-5406,
139304-EP2270008A1,
139304-EP2292617A1,
J-523585,
BRD-K02130563-001-07-2,
(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide,
(E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indole-3-yl)ethyl]amino]methyl]phenyl]acrylamide,
N-hydroxy-3 -[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide,
N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide,
(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide,
Panobinostat;(E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)acrylamide,
Panobinostat lactate,
Panobinostat [INN],
D0E3SH,
NVP LBH589,
panobinostat lactate anhydrous,
cc-487,
C21H23N3O2,
AN-1317,
CID6918837,
Panobinostat, NVP-LBH589, LBH589,
A10518,
C496932,
D000077767,
2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2E)-,